XML 61 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Information By Business Segments (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Financial Information By Business Segments
PSE&GPSEG Power & OtherEliminations (A)Consolidated Total
Millions
Three Months Ended September 30, 2023
Operating Revenues$1,999 $546 $(89)$2,456 
Net Income (B)401 (262)— 139 
Gross Additions to Long-Lived Assets813 103 — 916 
Nine Months Ended September 30, 2023
Operating Revenues$5,954 $3,475 $(797)$8,632 
Net Income (B)1,224 793 — 2,017 
Gross Additions to Long-Lived Assets2,149 211 — 2,360 
Three Months Ended September 30, 2022
Operating Revenues$1,953 $433 $(114)$2,272 
Net Income (Loss) (B)399 (285)— 114 
Gross Additions to Long-Lived Assets700 97 — 797 
Nine Months Ended September 30, 2022
Operating Revenues$5,905 $1,691 $(935)$6,661 
Net Income (Loss) (B)1,213 (970)— 243 
Gross Additions to Long-Lived Assets1,871 217 — 2,088 
As of September 30, 2023
Total Assets$41,867 $7,916 $(231)$49,552 
Investments in Equity Method Subsidiaries$— $15 $— $15 
As of December 31, 2022
Total Assets$39,960 $9,285 $(527)$48,718 
Investments in Equity Method Subsidiaries$— $306 $— $306 
(A)Intercompany eliminations primarily relate to intercompany transactions between PSE&G and PSEG Power. For a further discussion of the intercompany transactions between PSE&G and PSEG Power, see Note 19. Related-Party Transactions.
(B)Includes net after-tax gains (losses) of $(17) million and $(214) million for the three months and $750 million and $(896) million for the nine months ended September 30, 2023 and 2022, respectively, at PSEG Power related to the impacts of non-trading commodity mark-to-market activity, which consist of the financial impact from positions with future delivery dates. Includes a $239 million after-tax pension charge due to the remeasurement of the qualified pension plans as a result of the pension settlement transaction for the three and nine months ended September 30, 2023. See Note 9. Pension and Other Postretirement Benefits (OPEB) .